AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇳🇬

Bisoprolol Fumarate in Nigeria

11 products registered with NAFDAC 11 active

Brand / ProductReg. No.HolderStatusExpires
Bisoprolol 5 mg Tablets**
Tablet
B4-7693Novartis Nigeria Limitedactive27 Feb 2029
Bisoprolol 2.5 mg Tablet
Tablet
B4-7692Novartis Nigeria Limitedactive29 Nov 2028
Bisoprolol 10 mg Tablet
Tablet
B4-7694Novartis Nigeria Limitedactive29 Nov 2028
Concor 2.5 mg Tablet**
Tablet
B4-7135Merck Pharmaceutical and Life Sciences Limitedactive27 Mar 2028
Corbis 10 Tablet
Tablet
A4-4671Phillips Pharmaceuticals (Nigeria) Limitedactive22 Feb 2028
Corbis-5 Tablets
Tablet
A4-4672Phillips Pharmaceuticals (Nigeria) Limitedactive22 Feb 2028
Concor 10 mg Tablet
Tablet
B4-5412Merck Pharmaceutical and Life Sciences Limitedactive27 Oct 2026
Concor 5 mg Tablet
Tablet
B4-5411Merck Pharmaceutical and Life Sciences Limitedactive27 Oct 2026
Bisoprolol 7.5 mg Tablet
Tablet
C4-1317SK Medicines Limitedactive29 Nov 2025
Bisoprolol 2.5 mg Tablet
Tablet
C4-1318SK Medicines Limitedactive29 Nov 2025
B-Cor 5 Tablet
Tablet
04-8630Afrab-Chem Limitedactive27 Sept 2025

Bisoprolol FumarateNAFDAC Registration Details

NAFDAC (Nigeria) has 11 registered products containing Bisoprolol Fumarate, of which 11 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.

Track Bisoprolol Fumarate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Bisoprolol Fumarate — Nigeria (NAFDAC) | AfricaRegulatory